Bristol Myers Squibb's Commitment to Environment, Social and Governance: Our Progress & Aspirational Goals

July 22, 2024 9:45 AM

NORTHAMPTON, MA / ACCESSWIRE / July 22, 2024 / Bristol Myers Squibb CompanyOur Approach to ESGAt BMS, we understand that the future of our company, employees, communities, and the planet are inextricably linked. Our passion for making an impact extends beyond the discovery, development and delivery of innovative medicines that help patients prevail over serious diseases. Through our ESG strategy, we seek to mobilize our capabilities and...

Read more

Lovemère Introduces the Smallest Ever Warming Lactation Massager to Enhance Breastfeeding and Pumping for Moms

July 22, 2024 9:06 AM

SINGAPORE, SINGAPORE / ACCESSWIRE / July 10, 2024 / Lovemère, a prominent innovator in maternity and nursing wear, proudly announces the launch of its latest product: the Lovemère Warming Lactation Massager. Designed to offer unmatched comfort and relief, this compact device aims to improve the breastfeeding and pumping experience for mothers.The Smallest Ever, Yet Most PowerfulThe Lovemère Warming Lactation Massager distinguishes itself as the...

Read more

A Place At Home Celebrates Strong First Half of 2024 With Eight New Units

July 22, 2024 9:00 AM

A Place At Home, a senior-focused home care provider franchise, is entering the second half of 2024 with momentum from a strong first half. The franchise successfully added eight new units, bringing the total to 59 across the nation."Our growth is a testament to the effectiveness of our proven business model and the demand for our services," said Jason Evanich, president and co-founder of A Place At Home. "Many of our franchisees are headed for...

Read more

Omni-Biotic AB 10 Wins Product of the Year at NutraIngredients USA Awards 2024

July 22, 2024 8:00 AM

NEW YORK, NY / ACCESSWIRE / July 22, 2024 / Omni-Biotic US is proud to announce that Omni-Biotic AB 10 has been awarded "Product of the Year" in the "Microbiome Modulation" category at this year's prestigious NutraIngredients USA Awards.Omni-Biotic AB 10 Omni-Biotic AB 10 Box and Sachet The judges highlighted Omni-Biotic AB 10's exceptional impact on gut health and its innovative approach to addressing gut dysbiosis, stating: "Supported by trial...

Read more

MIRA Pharmaceuticals Reveals Preclinical Success: Ketamir-2 Optimized for Brain Delivery, Avoiding Ketamine's Drug Resistance

July 22, 2024 8:00 AM

MIAMI, FL / ACCESSWIRE / July 22, 2024 / MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA) ("MIRA" or the "Company"), a leading pre-clinical-stage pharmaceutical company, today announced new preclinical study results for its novel oral ketamine analog, Ketamir-2.The additional data announced today continues a string of promising preclinical results announced by MIRA in recent months for Ketamir-2 as MIRA works towards its goal of submitting an...

Read more

Protagonist Therapeutics to Participate in the BTIG Virtual Biotechnology Conference 2024

July 22, 2024 7:00 AM

Protagonist Therapeutics, Inc. (NASDAQ:PTGX) ("Protagonist" or the "Company") today announced that Dinesh V. Patel, Ph.D., President and Chief Executive Officer, will participate in a fireside chat and one-on-one meetings at the BTIG Virtual Biotechnology Conference.BTIG Virtual Biotechnology Conference - August 5-6, 2024Format: Fireside ChatDay/Time: Tuesday, August 6 at 2:00-2:35 P.M. EDTIf you are interested in meeting with the Protagonist...

Read more

Biotricity Announces Continued Margin Improvement Driven by its Proprietary AI Cloud

July 22, 2024 7:00 AM

REDWOOD CITY, CA / ACCESSWIRE / July 22, 2024 / Biotricity Inc. (Nasdaq:BTCY), a Technology-as-a-Service (TaaS) company operating in the remote cardiac monitor sector of consumer healthcare, today announced ongoing improvements in operational efficiency, scalability and margin performance driven by the latest enhancements to the company's proprietary AI Cloud platform.The latest version of Biotricity's AI Cloud has improved the company's tech...

Read more

Tonix Pharmaceuticals Awarded Potential 34 million dollar Contract with U.S. Department of Defense

July 22, 2024 4:50 AM

Tonix Pharmaceuticals CEO Dr. Seth Lederman joined Steve Darling from Proactive to share exciting news about a significant achievement for the company. Tonix Pharmaceuticals has been awarded a potential contract worth up to $34 million over five years by the Defense Threat Reduction Agency (DTRA), an agency within the U.S. Department of Defense. This contract aims to develop small molecule broad-spectrum antiviral agents for the prevention or...

Read more

Cantargia Reports Organisational Change

July 22, 2024 2:50 AM

LUND, SWEDEN / ACCESSWIRE / July 22, 2024 / Cantargia (STO:CANTA) Cantargia (Cantargia AB; Nasdaq Stockholm:CANTA) today announced that its Chief Operating Officer (COO), Liselotte Larsson has resigned and will continue her career outside Cantargia. She will depart her role by mid-October, 2024."Liselotte joined Cantargia before our public listing and has played an important role to advance Cantargia's two projects into clinical stage, for which...

Read more

Biophytis Deploys its Partnership Strategy and Signs Two Contracts with Local Agents in Asia

July 22, 2024 2:30 AM

Biophytis SA (Euronext Growth Paris:ALBPS), ("Biophytis" or the "Company"), a clinical-stage biotechnology company specializing in the development of treatments for age-related diseases, today announces the deployment of its partnership strategy in Asia.To expand its presence in this strategic region, Biophytis has today signed two contracts with local agents: one for Japan and South Korea, the other for China and Southeast Asia. These agents...

Read more

Lovemère Introduces the Smallest Ever Warming Lactation Massager to Enhance Breastfeeding and Pumping for Moms

July 20, 2024 11:25 AM

SINGAPORE, SINGAPORE / ACCESSWIRE / July 10, 2024 / Lovemère, a prominent innovator in maternity and nursing wear, proudly announces the launch of its latest product: the Lovemère Warming Lactation Massager. Designed to offer unmatched comfort and relief, this compact device aims to improve the breastfeeding and pumping experience for mothers.The Smallest Ever, Yet Most PowerfulThe Lovemère Warming Lactation Massager distinguishes itself as the...

Read more

Healthcare AI Acquisition Corp. Announces Receipt of Nasdaq Deficiency Letter

July 19, 2024 4:30 PM

Healthcare AI Acquisition Corp. (NASDAQ:HAIA) (the "Company"), a special purpose acquisition company, announced today that it received a notification letter from The Nasdaq Stock Market ("Nasdaq") that it was not in compliance with Nasdaq Listing Rule 5250(c)(1) as it had failed to timely file its Quarterly Report on Form 10-Q for the period ended March 31, 2024 (the "Form 10-Q"). Under the Nasdaq Listing Rules, the Company now has 60 calendar...

Read more

Cosmos Health Regains Compliance with Nasdaq Minimum Bid Price Rule

July 19, 2024 11:40 AM

CHICAGO, IL / ACCESSWIRE / July 19, 2024 / Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in innovative R&D, owner of proprietary pharmaceutical and nutraceutical brands, manufacturer and distributor of healthcare products, and operator of a telehealth platform, announced today that it has regained compliance with the minimum bid price requirement of...

Read more

Ottobock Leads the Charge in Expanding Access to Prosthetics for Underserved Patients

July 19, 2024 10:55 AM

AUSTIN, TX / ACCESSWIRE / July 19, 2024 / Medicare officially announces LCD changes that expand access to microprocessor-controlled knees (MPKs) for lower mobility users - a group that is often overlooked as users of this groundbreaking technology (view the changes here). Ottobock has been the driving force behind the expansion of Medicare coverage of MPKs for low-mobility patients, leading the way with two decades of research and advocacy. As...

Read more

Bausch Health Welcomes Two New Members to the Executive Leadership Team

July 19, 2024 7:00 AM

LAVAL, QC / ACCESSWIRE / July 19, 2024 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) today announced the appointment of two new members to its Executive Leadership Team (ELT).Jean-Jacques Charhon ("JJ") will join the Company as Chief Financial Officer on August 19, 2024. JJ has over 25 years of experience in financial leadership roles with public and private companies across healthcare, high tech and services, primarily at General Electric,...

Read more

Join Nutriband's Exclusive Live Investor Webinar and Q&A Session on July 25

July 19, 2024 7:00 AM

Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW), a developer of transdermal pharmaceutical solutions, is pleased to invite investors to a webinar on July 25, 2024, at 4:15 p.m. ET.The exclusive event, hosted by RedChip Companies, will feature Nutriband Chairman and President Serguei Melnik and Chief Executive Officer Gareth Sheridan, who will share insight into the Company's current operations and upcoming milestones. Nutriband stands at the...

Read more

Senzime Expands Contract with Leading US Hospital System

July 19, 2024 5:00 AM

UPPSALA, SE / ACCESSWIRE / July 19, 2024 / Senzime (STO:SEZI)(OTCQX:SNZZF) Senzime, an industry leader in algorithm-based patient monitoring solutions, today announced a new contract with a leading, top-10 ranked Integrated Delivery Network (IDN) healthcare system in Southeastern United States. The contract extends TetraGraph monitor usage into adult care following successful utilization in pediatric surgeries within the IDN. With the expanded...

Read more

Champions Oncology Reports Quarterly Revenue of $14.0 Million

July 18, 2024 4:00 PM

Champions Oncology, Inc. (Nasdaq:CSBR), a leader in the development of advanced preclinical oncology solutions, today announced its financial results for the fiscal year and fourth quarter ended April 30, 2024.Fourth Quarter Financial Highlights:Fourth quarter revenue increased 7% to $14 millionAdjusted EBITDA fourth quarter income of $884,000Fourth quarter gross margin on pharmacology services of 49%Fiscal Year 2024 Financial Highlights:Annual...

Read more

Cosmos Health's Cana Secures Additional Contract Manufacturing Agreement with Provident Pharmaceuticals for 700,000 Units, Bringing Total Order Book to 5.02 Million Units

July 18, 2024 3:45 PM

CHICAGO, IL / ACCESSWIRE / July 18, 2024 / Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in innovative R&D, owner of proprietary pharmaceutical and nutraceutical brands, manufacturer and distributor of healthcare products, and operator of a telehealth platform, announced today that its wholly-owned subsidiary, Cana Laboratories ('Cana'), has secured...

Read more

Baptist Health Breaks Ground On Third Combined ER and Urgent Care Facility

July 18, 2024 3:30 PM

Innovative Facility on Bardstown Road Continues Expansion of Patient-First Healthcare ModelLOUISVILLE, KY / ACCESSWIRE / July 18, 2024 / Baptist Health Kentucky, in partnership with Dallas-based Intuitive Health, today broke ground on its third dual emergency and urgent care facility. Baptist Health ER & Urgent Care Glenmary is located at 7702 Bardstown Road, Louisville, KY 40291. This 11,400-square-foot facility is scheduled to open in the...

Read more